We'd appreciate your feedback. Send feedback Subscribe to our newsletters and alerts


Annals of Pharmacy Practice and Pharmacotherapy

2022 Volume 2
Creative Commons License

Atypical Pneumonia: Diagnostic Challenges and Therapeutic Approaches


, , , , , , , , , , ,
  1. Faculty of Medicine, King Faisal University, Al Ahsa, KSA.
  2. Faculty of Medicine, Imam Mohammed Bin Saud Islamic University, Riyadh, KSA.
  3. Faculty of Medicine, King Khalid University, Abha, KSA.
  4. Faculty of Medicine, King Abdulaziz University, Jeddah, KSA.
  5. Faculty of Medicine, Ibn Sina National College of Medicine, Jeddah, KSA.
  6. Faculty of Medicine, Jazan University, Jazan, KSA.
  7. Faculty of Medicine, Tabuk University, Tabuk, KSA.
  8. Faculty of Medicine, Tabuk University, Tabuk, KSA.
  9. Faculty of Pharmacy, Qassim University, Qassim, KSA.
  10. Faculty of Medicine, Aljouf University, Aljouf, KSA.
  11. Emergency Department, King Abdul Aziz Specialist Hospital, Taif, KSA.
Abstract

Atypical pneumonia refers to a group of lower respiratory tract infections caused by specific respiratory pathogens that differ clinically and radiologically from typical bacterial community-acquired pneumonia (CAP). These infections involve both zoonotic and non-zoonotic transmission routes, with non-zoonotic cases being more common. A key distinguishing feature of atypical CAP is its frequent extrapulmonary involvement, which distinguishes it from the classic presentation of CAP. Therefore, recognition of clinical syndromes plays an important role in increasing clinical suspicion, guiding the initiation of empirical antibiotic therapy, and supporting targeted diagnostic evaluations. This review aims to consolidate current knowledge to improve the understanding and clinical recognition of atypical pneumonia. We performed a comprehensive literature search on PubMed, focusing on the clinical presentation, diagnostic approach, and management of atypical pneumonia. The causative pathogens are often associated with systemic effects and a wide range of extrapulmonary manifestations. Furthermore, some of these organisms pose challenges in laboratory identification due to their difficulty in cultivation and the risks associated with isolation. Consequently, syndromic diagnosis remains essential in initiating timely treatment and directing further diagnostic workup.


How to cite this article
Vancouver
Al-Abbad EA, Albarrak YAI, Al Shuqayfah NI, Nahhas AA, Alnemari AF, Alqurashi RK, et al. Atypical Pneumonia: Diagnostic Challenges and Therapeutic Approaches. Ann Pharm Pract Pharmacother. 2022;2:10-9. https://doi.org/10.51847/6mykfn3wLH
APA
Al-Abbad, E. A., Albarrak, Y. A. I., Al Shuqayfah, N. I., Nahhas, A. A., Alnemari, A. F., Alqurashi, R. K., Thiyab, S. H. M. A., Alqubali, M. K., Alhawiti, M. A., Almutairi, S. M., et al. (2022). Atypical Pneumonia: Diagnostic Challenges and Therapeutic Approaches. Annals of Pharmacy Practice and Pharmacotherapy, 2, 10-19. https://doi.org/10.51847/6mykfn3wLH

About GalaxyPub

Find out more

Our esteemed publisher is committed to advancing medical knowledge through rigorous research dissemination. We exclusively accept submissions related to the field of medicine.

Our journals provide a platform for clinicians, researchers, and scholars to share groundbreaking discoveries, clinical insights, and evidence-based practices. By maintaining this specialized focus, we ensure that their publications contribute significantly to the advancement of healthcare worldwide.